| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.087 | 0.09 |